Rectal cancer chemoradiotherapy was tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

Pathologic complete response does not predict overall or disease-free survival in patients with rectal cancer, according to a ...

A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, ...

The American Cancer Society says an uptick in colon cancer cases in the 45-49 age group is a result of lowered screening ages ...

Colorectal cancer cases are increasing among adults under 50, with screening guidelines now recommending starting at age 45.

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

The tissue damage, anatomical distortion, and lack of surgical landmarks caused by the primary treatment present major challenges to surgeons performing salvage RARP.

A stunning clinical trial has delivered results that doctors rarely see. Every single patient in the study saw their rectal ...

An expert discusses how clinics can successfully implement gene therapy workflows by establishing strong institutional protocols, assigning dedicated clinic coordinators, and using strategies like ...

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and ...

A new study raises concerns about a widely used shortcut in approving rectal cancer drugs, showing that the absence of detectable tumors after treatment—known as pathologic complete response ...